Global Medical REIT Inc. Amends and Restates Credit Facility
– Extends Loan Maturities and Enters into Forward Starting Interest Rate Swaps to Hedge Term Loans –
– Weighted Average Term of the Company’s Debt Increases from 1.3 Years to 4.4 Years –
-
Extends the initial maturity date of the existing
$400 million revolver component of the credit facility toOctober 2029 with two, six-month extension options available at the Company’s election to extend the maturity toOctober 2030 ; and -
Extends the maturity of the existing
$350 million Term Loan A, dividing it into three term loans structured as follows:$100 million term loan maturing inOctober 2029 (“Term Loan A-1”);$100 million term loan maturing inOctober 2030 (“Term Loan A-2”); and$150 million term loan maturing inApril 2031 (“Term Loan A-3”); and
- Removes the previous 0.10% (10 basis point) secured overnight financing rate (“SOFR”) credit spread adjustment on all credit facility borrowings.
The credit facility’s pricing grid,
In connection with the Amended and Restated Credit Facility, the Company entered into
|
Term Loan A Tranches |
Interest Rate Swap Term |
Fixed Base Rate |
Effective
|
|||
|
|
|
3.24% |
4.75% |
|||
|
|
|
3.28% |
4.80% |
|||
|
|
|
3.32% |
4.84% |
|||
|
(1) Rates consist of the fixed SOFR base rate plus a borrowing spread of 1.45% based on a leverage ratio of between 45% and 50% and is calculated using 365/360 method. |
||||||
The existing
At closing of the Amended and Restated Credit Facility, the weighted average term of the Company’s debt, including the drawn revolver component, was 4.4 years.
The Joint Lead Arrangers and Joint Book Runners for the facility were
About
Forward-Looking Statements
Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008895076/en/
Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869
Source: